ScienceMed®

Risk-of-bias assessment using Cochrane's revised tool for randomized trials (RoB 2) was useful but challenging and resource-intensive: observations from a systematic review

Medicina e Tecnologia
Imagem de arquivo, ilustrativa — não é do estudo. Lâmina de silício com circuitos integrados. Inductiveload · domínio público · Wikimedia Commons

Revisão sistemáticaNível 1 · Evidência consolidadaJournal of clinical epidemiology24 jun 2023185 citações

Salvar

Resumo original em inglês

O que aconteceu

To report our experience using version 2 of the Cochrane risk-of-bias tool for randomized trials (RoB 2).

Two reviewers independently applied RoB 2 to results of interest in a large systematic review of complex interventions and reached consensus. We recorded the time taken, and noted and discussed our difficulties using the tool, and the resolutions we adopted. We explored the time taken with regression analysis and summarized our experience of implementing the tool.

O que encontraram

We assessed risk of bias in 860 results of interest in 113 studies. Staff resource averaged 358 minutes per study (SD 183). Number of results (β = 22) and reports (β = 14) per study and experience of the team (β = -6) significantly affected assessment time. To implement the tool consistently, we developed cut points for missingness and considerations of balance regarding missingness, assumed some concerns with intervention deviations unless otherwise prevented or investigated, some concerns with measurements from unblinded self-reporting participants, and judged low risk of selection for certain dichotomous outcomes despite the absence of an analysis plan.

Por que isso importa

The RoB 2 tool and guidance are useful but resource-intensive and challenging to implement. Critical appraisal tools and reporting guidelines should detail risk of bias implementation. Improved guidance focusing on implementation could assist reviewers.

Resumo publicado sob licença CC BY. A tradução para o português ainda não chegou a este estudo.

O estudo original

Risk-of-bias assessment using Cochrane's revised tool for randomized trials (RoB 2) was useful but challenging and resource-intensive: observations from a systematic review

Thomas Frederick Crocker, Natalie Lam, Magda Jordão, Caroline Brundle, Matthew Prescott, Anne Forster, Joie Ensor, John Gladman, Andrew Clegg

Descritores MeSH

  • Research Report
  • Humans
  • Bias
  • Randomized Controlled Trials as Topic

Veja também

Estudos relacionados